메뉴 건너뛰기




Volumn 60, Issue 5, 2007, Pages 1060-1063

Effect of plaunotol in combination with clarithromycin against clarithromycin-resistant Helicobacter pylori in vitro and in vivo

Author keywords

Cytoprotective anti ulcer agent; Eradication; Synergistic effect

Indexed keywords

CLARITHROMYCIN; PLAUNOTOL;

EID: 35449002947     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkm329     Document Type: Article
Times cited : (7)

References (17)
  • 1
    • 33847650869 scopus 로고    scopus 로고
    • Overview: Helicobacter pylori and extragastric disease
    • Suzuki H, Marshall BJ, Hibi T. Overview: Helicobacter pylori and extragastric disease. Int J Hematol 2006; 84: 291-300.
    • (2006) Int J Hematol , vol.84 , pp. 291-300
    • Suzuki, H.1    Marshall, B.J.2    Hibi, T.3
  • 2
    • 33847660516 scopus 로고    scopus 로고
    • Helicobacter pylori: Present status and future prospects in Japan
    • Suzuki H, Hibi T, Marshall BJ. Helicobacter pylori: Present status and future prospects in Japan. J Gastroenterol 2007; 42: 1-15.
    • (2007) J Gastroenterol , vol.42 , pp. 1-15
    • Suzuki, H.1    Hibi, T.2    Marshall, B.J.3
  • 3
    • 0025331686 scopus 로고
    • Cure of duodenal ulcer associated with eradication of Helicobacter pylori
    • Rauws EA, Tytgat GN. Cure of duodenal ulcer associated with eradication of Helicobacter pylori. Lancet 1990; 335: 1233-5.
    • (1990) Lancet , vol.335 , pp. 1233-1235
    • Rauws, E.A.1    Tytgat, G.N.2
  • 4
    • 0034855743 scopus 로고    scopus 로고
    • A multicenter, double-blind study on triple therapy with lansoprazole, amoxicillin and clarithromycin for eradication of Helicobacter pylori in Japanese peptic ulcer patients
    • Asaka M, Sugiyama T, Kato M et al. A multicenter, double-blind study on triple therapy with lansoprazole, amoxicillin and clarithromycin for eradication of Helicobacter pylori in Japanese peptic ulcer patients. Helicobacter 2001; 6: 254-61.
    • (2001) Helicobacter , vol.6 , pp. 254-261
    • Asaka, M.1    Sugiyama, T.2    Kato, M.3
  • 5
    • 0033983566 scopus 로고    scopus 로고
    • Relationship between eradication therapy and clarithromycin-resistant Helicobacter pylori in Japan
    • Hoshiya S, Watanabe K, Tokunaga K et al. Relationship between eradication therapy and clarithromycin-resistant Helicobacter pylori in Japan. J Gastroenterol 2000; 35: 10-4.
    • (2000) J Gastroenterol , vol.35 , pp. 10-14
    • Hoshiya, S.1    Watanabe, K.2    Tokunaga, K.3
  • 6
    • 18644362493 scopus 로고    scopus 로고
    • Eradication rates of clarithromycin-resistant Helicobacter pylori using either rabeprazole or lansoprazole plus amoxicillin and clarithromycin
    • Murakami K, Sato R, Okimoto T et al. Eradication rates of clarithromycin-resistant Helicobacter pylori using either rabeprazole or lansoprazole plus amoxicillin and clarithromycin. Aliment Pharmacol Ther 2002; 16: 1933-8.
    • (2002) Aliment Pharmacol Ther , vol.16 , pp. 1933-1938
    • Murakami, K.1    Sato, R.2    Okimoto, T.3
  • 7
    • 18644378213 scopus 로고    scopus 로고
    • The relationship between consumption of antimicrobial agents and the prevalence of primary Helicobacter pylori resistance
    • Perez Aldana L, Kato M, Nakagawa S. et al. The relationship between consumption of antimicrobial agents and the prevalence of primary Helicobacter pylori resistance. Helicobacter 2002; 7: 306-9.
    • (2002) Helicobacter , vol.7 , pp. 306-309
    • Perez Aldana, L.1    Kato, M.2    Nakagawa, S.3
  • 8
    • 1842508149 scopus 로고    scopus 로고
    • Characteristics and trends of clarithromycin-resistant Helicobacter pylori isolates in Japan over a decade
    • Masuda H, Hiyama T, Yoshihara M et al. Characteristics and trends of clarithromycin-resistant Helicobacter pylori isolates in Japan over a decade. Pathobiology 2004; 71: 159-63.
    • (2004) Pathobiology , vol.71 , pp. 159-163
    • Masuda, H.1    Hiyama, T.2    Yoshihara, M.3
  • 9
    • 0029903276 scopus 로고    scopus 로고
    • In-vitro and in-vivo antibacterial activity of plaunotol, a cytoprotective antiulcer agent, against Helicobacter pylori
    • Koga T, Kawada H, Utsui Y et al. In-vitro and in-vivo antibacterial activity of plaunotol, a cytoprotective antiulcer agent, against Helicobacter pylori. J Antimicrob Chemother 1996; 37 919-29.
    • (1996) J Antimicrob Chemother , vol.37 , pp. 919-929
    • Koga, T.1    Kawada, H.2    Utsui, Y.3
  • 10
    • 0035996118 scopus 로고    scopus 로고
    • Effect of plaunotol in combination with clarithromycin or amoxicillin on Helicobacter pylori in vitro and in vivo
    • Koga T, Inoue H, Ishii C et al. Effect of plaunotol in combination with clarithromycin or amoxicillin on Helicobacter pylori in vitro and in vivo. J Antimicrob Chemother 2002; 50: 133-6.
    • (2002) J Antimicrob Chemother , vol.50 , pp. 133-136
    • Koga, T.1    Inoue, H.2    Ishii, C.3
  • 12
    • 0013575179 scopus 로고    scopus 로고
    • Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994
    • Dixon MF, Genta RM, Yardley JH et al. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol 1996; 20: 1161-81.
    • (1996) Am J Surg Pathol , vol.20 , pp. 1161-1181
    • Dixon, M.F.1    Genta, R.M.2    Yardley, J.H.3
  • 13
    • 32944475349 scopus 로고    scopus 로고
    • Suppressive effects of fruit-juice concentrate of Prunus mume Sieb. et Zucc. (Japanese apricot, Ume) on Helicobacter pylori-induced glandular stomach lesions in Mongolian gerbils
    • Otsuka T, Tsukamoto T, Tanaka H et al. Suppressive effects of fruit-juice concentrate of Prunus mume Sieb. et Zucc. (Japanese apricot, Ume) on Helicobacter pylori-induced glandular stomach lesions in Mongolian gerbils. Asian Pac J Cancer Prev 2005; 6 337-41.
    • (2005) Asian Pac J Cancer Prev , vol.6 , pp. 337-341
    • Otsuka, T.1    Tsukamoto, T.2    Tanaka, H.3
  • 14
    • 4344591515 scopus 로고    scopus 로고
    • Second-line treatment of Helicobacter pylori infection after dilution agar methods and PCR-RFLP analysis
    • Masaoka T, SuzukiKurabayeshi HK, Kamiya AG et al. Second-line treatment of Helicobacter pylori infection after dilution agar methods and PCR-RFLP analysis. Aliment Pharmacol Ther 2004; 20 Suppl 1: 68-73.
    • (2004) Aliment Pharmacol Ther , vol.20 , Issue.SUPPL. 1 , pp. 68-73
    • Masaoka, T.1    SuzukiKurabayeshi, H.K.2    Kamiya, A.G.3
  • 15
    • 0031873739 scopus 로고    scopus 로고
    • Interactions of plaunotol with bacterial membranes
    • Koga T, Watanabe H, Kawada H et al. Interactions of plaunotol with bacterial membranes. J Antimicrob Chemother 1998; 42: 133-40.
    • (1998) J Antimicrob Chemother , vol.42 , pp. 133-140
    • Koga, T.1    Watanabe, H.2    Kawada, H.3
  • 16
    • 0029120666 scopus 로고
    • Combination therapy with mucosal protective agent for the eradication of Helicobacter pylori
    • Fukuda Y, Yamamoto I, Okui M et al. Combination therapy with mucosal protective agent for the eradication of Helicobacter pylori. Eur J Gastroenterol Hepatol 1995; 7 Suppl 1: S45-7.
    • (1995) Eur J Gastroenterol Hepatol , vol.7 , Issue.SUPPL. 1
    • Fukuda, Y.1    Yamamoto, I.2    Okui, M.3
  • 17
    • 33645768501 scopus 로고    scopus 로고
    • Gatifloxacin resistance and mutations in gyrA after unsuccessful Helicobacter pylori eradication in Japan
    • Nishizawa T, Suzuki H, Kurabayashi K et al. Gatifloxacin resistance and mutations in gyrA after unsuccessful Helicobacter pylori eradication in Japan. Antimicrob Agents Chemother 2006; 50: 1538-40.
    • (2006) Antimicrob Agents Chemother , vol.50 , pp. 1538-1540
    • Nishizawa, T.1    Suzuki, H.2    Kurabayashi, K.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.